The global gemcitabine HCI market is on a positive growth trajectory, primarily driven by the rising incidence of cancer across the world. Projecting the Gemcitabine HCl market growth at an impressive CAGR of 6.9%, a new market study by Fact.MRsource https://www.openpr.com/news/2242765/gemcitabine-hcl-market-competitive-analysis-statistics
